What treatment strategy should the staff discuss with Mr. Baker's physician to help with medication compliance?

The use of fluphenazine (Prolixin) decanoate is considered an effective treatment strategy for improving medication compliance, especially in patients who may struggle with consistently taking oral medications. Fluphenazine decanoate is a long-acting injectable antipsychotic, which means it is administered less frequently than daily medications, typically every two to four weeks. This reduces the burden of daily medication adherence and can significantly enhance compliance, especially in individuals with difficulties related to memory, motivation, or insight into their illness.

In contrast, oral medications like fluoxetine may require daily adherence, which can be challenging for some patients. While motivational interviewing techniques are valuable in encouraging compliance, they may not be as immediately effective in ensuring medication adherence as implementing a long-acting injectable form of medication. Additionally, the use of lorazepam is generally not focused on long-term compliance strategies, as it is primarily prescribed for short-term management of anxiety symptoms rather than stable maintenance of psychiatric conditions. Thus, utilizing fluphenazine decanoate effectively addresses the long-standing issue of medication compliance by minimizing the frequency of dosing and enhancing the likelihood that the patient will receive their necessary treatment.